Though initially characterized as an integral member in membrane trafficking [31,32,33], studies have revealed the tumorigenic role of PLEKHA8 in various cancers, including HCC by enhancing the Wnt/β-catenin pathway [33,34,35,36]. Here, PLEKHA8 is linked to cancer.